Abstract: A method of detecting and repairing paint defects on a vehicle body (10) is provided, including developing paint defect data using electronic imaging of the vehicle body (S1), referencing said electronic imaging with vehicle CAD data to develop three dimensional paint defect coordinates for each paint defect (S2), storing said paint defect data and said paint defect coordinates referenced to the vehicle body (S3), developing a repair strategy based upon said paint defect data and said paint defect coordinates (S4), and performing an automated repair on the paint defects based upon said repair strategy (S5).

Abstract: An apparatus embodying the invention includes a probe head with an interrogation surface that is intended to be positioned adjacent or pushed into contact with a target material or tissue. The probe head is constructed to have a plurality of interrogation devices arranged across the face of the interrogation surface. The probe head is also constructed so that the interrogation device can conform to a non-uniform or non-planar surface of the target tissue. In some embodiments, the interrogation surface may have a particular shape that conforms to the shape of a target material. In other embodiments, one or more portions of the interrogation surface could be movable with respect to the remaining portions so that the interrogation surface could be movable with respect to remaining portions so that the interrogation surface can the thereby conform to a non-uniform surface. In still other embodiments, a plurality of separately moveable interrogation devices can be arranged across the interrogation surface.

Abstract: A process for in situ gasification of mineral oil in a subterranean formation comprises running a tool having a controllable thermal device therein from a surface production facility down to the subterranean formation, bringing said tool into operational proximity with the mineral oil in said subterranean formation, and activating the tool to operate the thermal device within a predetermined temperature range to generate gases or oily vapours from said mineral oil, which permits either an enhanced oil recovery (EOR) method with reduced water contamination, or a gas production process (GPP) which is useful in reducing environmental risks normally associated with transport of crude oil.

Abstract: A process for recovering clay from contaminated clay-containing waste materials e.g. drill-cuttings arising from offshore/onshore oil & gas exploration and production processes, comprises a cleaning step to generate a clay of sufficient purity for reuse, and a particle sizing step to obtain a substantially consistent quality clay product optionally in the form of bulk particles or shaped to provide conveniently transportable product forms including granules, pellets, prills, packing elements, briquettes and the like shaped articles.

Abstract: Compound having the structure where anthracycline, N, Ra, X, Rb, n and m are as defined in the specification. The compound of the invention is activatable in vivo by esterases and spontaneous dehydration to form an aldehyde. The aldehyde may couple to nucleophiles of intracellular macromolecules. The compounds of the invention are cytotoxically effective in the inhibition of human myeloma cells.

Abstract: A fiber optic probe is provided that includes a housing, at least one optical fiber disposed within the housing, one end of each of the at least one optical fiber being disposed adjacent an opening in the housing forming a probe face, a binding agent that binds the at least one optical fiber within the housing, and a protective coating sealingly covering the probe face to prevent contaminants from contacting the at least optical fiber. A method for protecting a fiber optic probe having a housing, at least one optical fiber disposed within the housing, one end of each of the at least one optical fiber being disposed adjacent an opening in the housing forming a probe face, and a binding agent that binds the at least one optical fiber within the housing, includes polishing the probe face to create a substantially flat probe face, cleaning the probe face after polishing the probe face and sealing the probe face with a protective coating.

Abstract: A cross block for use in a pneumatic conveying system. The pneumatic conveying system includes a substantially enclosed plenum and at least two bottle neck support means to support the neck of bottles or containers suspended from the plenum. The cross block comprises a frame member having means to maintain the bottle neck support means in a generally parallel and co-planer relationship to thereby help maintain the vertical alignment of bottles or containers when suspended by the bottle neck support means and transported along the conveying system.

Abstract: A plenum for a pneumatic conveyor of the type used for the movement of bottles and the like. The plenum comprises a central housing for receiving pressurized air, a cross block positioned within the central housing and generally spanning across its width, at least two bottle neck supports permitting bottles to be suspended from the plenum, and an air diverter to divert pressurized air from the interior of the central housing to the bottle neck supports to drive bottles along the length of the plenum. The cross block fixes the vertical positioning of the bottle neck supports to maintain the bottle neck supports in a parallel and co-planer configuration thereby helping to maintain the vertical alignment of bottles and the like suspended from the plenum and facilitating in their movement along the length of the plenum.

Abstract: Compound having the structure 1

Abstract: A plenum for a pneumatic conveyor of the type used for the movement of bottles and the like. The plenum comprises a central housing for receiving pressurized air, a cross block positioned within the central housing and generally spanning across its width, at least two bottle neck supports permitting bottles to be suspended from the plenum, and an air diverter to divert pressurized air from the interior of the central housing to the bottle neck supports to drive bottles along the length of the plenum. The cross block fixes the vertical positioning of the bottle neck supports to maintain the bottle neck supports in a parallel and co-planer configuration thereby helping to maintain the vertical alignment of bottles and the like suspended from the plenum and facilitating in their movement along the length of the plenum.

Abstract: The present invention is a compound having the structure where: anthracycline is doxorubicin, daunorubicin or a derivative thereof; N is the 3′ nitrogen of daunosamine; Ra is H or alkyl; X is, O, S, CRc2 or NRc where Rc is H or alkyl; Rb is alkyl or aryl; n is 1 to 6; and m is 0 to 6. Ra and Rc are preferably H, methyl, ethyl, propyl or butyl, although other alkyl substituents are usable. Rb is alkyl or aryl. The compound of the present invention as described above is activatable in vivo by esterases and spontaneous dehydration to form an aldehyde. The aldehyde may couple to nucleophiles of intracellular macromolecules. The compounds of the present invention are cytotoxically effective in the inhibition of human myeloma cells.

Abstract: A process for treating naturally occurring radioactive material (NORM) comprises use of NORM as a mud constituent in a drilling mud manufacturing process and particle size reduction of the NORM particles during or before that process to attain a selected particle size corresponding to that of a particulate drilling mud component, said particle size reduction being optionally accompanied by additional mixing, if necessary, of the NORM and mud component particles, the aim of said use being the achievement of irreversible dilution of the NORM particles in said component to nullify the radioactive nature thereof.

Abstract: The present invention is a compound having the structure ##STR1##Work relating to the development of the present invention was supported by Grant CA 42708 from the National Institutes of Health, DHHS. This support gives the United States Government certain rights in the present invention .

Abstract: A compound having the structure: ##STR1## wherein R is CH.sub.3, C.sub.2 H.sub.5, C.sub.3 H.sub.7, t-C.sub.4 H.sub.9 or C.sub.6 H.sub.5 ; R.sup.1 is NH.sub.2, NHCH.sub.3, NHC.sub.2 H.sub.5, NHC.sub.3 H.sub.7, NHC.sub.4 H.sub.9, NHCH.sub.2 CH.sub.2 Cl, NHC.sub.6 H.sub.5, N(CH.sub.3).sub.2, N(C.sub.2 H.sub.5).sub.2, N(C.sub.3 H.sub.7).sub.2, NCH.sub.3 (C.sub.2 H.sub.5), NCH.sub.3 (C.sub.3 H.sub.7), N(CH.sub.2 CH.sub.2 Cl).sub.2, NHOH, NHNHCO.sub.2 CH.sub.2 C.sub.6 H.sub.5, NHNHCO.sub.2 C(CH.sub.3).sub.3, OCH.sub.3, OC.sub.2 H.sub.5, OC.sub.3 H.sub.7, OC.sub.4 H.sub.9, OC.sub.6 H.sub.5, OC.sub.2 C.sub.6 H.sub.5, CH.sub.3, C.sub.2 H.sub.5, C.sub.3 H.sub.7, C.sub.4 H.sub.9, CH.sub.2 NO.sub.2 or CH.sub.2 NH.sub.2 ; and R.sup.2 is NHCH.sub.2 CH.sub.2 Cl or N(CH.sub.2 CH.sub.2 Cl).sub.2.These compounds may be used to eliminate occult leukemic clonogenic cells from bone marrow by contacting the bone marrow with a solution comprising levels of said compound sufficient to eliminate occult leukemic clonogenic cells.

Abstract: A compound having the structure: ##STR1## wherein R is CH.sub.3, C.sub.2 H.sub.5, C.sub.3 H.sub.7, t--C.sub.4 H.sub.9 or C.sub.6 H.sub.5 ; R.sup.1 is NH.sub.2, NHCH.sub.3, NHC.sub.2 H.sub.5, NHC.sub.3 H.sub.7, NHC.sub.4 H.sub.9, NHCH.sub.2 CH.sub.2 Cl, NHC.sub.6 H.sub.5, N(CH.sub.3).sub.2, N(C.sub.2 H.sub.5).sub.2, N(C.sub.3 H.sub.7).sub.2, NCH.sub.3 (C.sub.2 H.sub.5), NCH.sub.3 (C.sub.3 H.sub.7), N(CH.sub.2 CH.sub.2 Cl).sub.2, NHOH, NHNHCO.sub.2 CH.sub.2 C.sub.6 H.sub.5, NHNHCO.sub.2 C(CH.sub.3).sub.3, OCH.sub.3, OC.sub.2 H.sub.5, OC.sub.3 H.sub.7, OC.sub.4 H.sub.9, OC.sub.6 H.sub.5, OC.sub.2 C.sub.6 H.sub.5, CH.sub.3, C.sub.2 H.sub.5, C.sub.3 H.sub.7, C.sub.4 H.sub.9, CH.sub.2 NO.sub.2 or CH.sub.2 NH.sub.2 ; and R.sup.2 is NHCH.sub.2 CH.sub.2 Cl or N(CH.sub.2 CH.sub.2 Cl).sub.2.These compounds may be used to eliminate occult leukemic clonogenic cells from bone marrow by contacting the bone marrow with a solution comprising levels of said compound sufficient to eliminate occult leukemic clonogenic cells.

Abstract: A method for purging tumor cells from bone marrow of a host, the method comprisingextracting bone marrow cells from the host;treating extracted bone marrow cells with a therapeutic level of a compound having the structure: ##STR1## wherein R is CH.sub.3, C.sub.2 H.sub.5, C.sub.3 H.sub.7, t-C.sub.4 H.sub.9 or C.sub.6 H.sub.5 ; R.sup.1 is NH.sub.2, NHCH.sub.3, NHC.sub.2 H.sub.5, NHC.sub.3 H.sub.7, NHC.sub.4 H.sub.9, NHCH.sub.2 CH.sub.2 Cl, NHC.sub.6 H.sub.5, N(CH.sub.3).sub.2, N(C.sub.2 H.sub.5).sub.2, N(C.sub.3 H.sub.7).sub.2, NCH.sub.3 (C.sub.2 H.sub.5), NCH.sub.3 (C.sub.3 H.sub.7), N(CH.sub.2 CH.sub.2 Cl).sub.2, NHOH, NHNHCO.sub.2 CH.sub.2 C.sub.6 H.sub.5, NHNHCO.sub.2 C(CH.sub.3).sub.3, OCH.sub.3, OC.sub.2 H.sub.5, OC.sub.3 H.sub.7, OC.sub.4 H.sub.9, OC.sub.6 H.sub.5, OCH.sub.2 C.sub.6 H.sub.5, CH.sub.3, C.sub.2 H.sub.5, C.sub.3 H.sub.7, C.sub.4 H.sub.9, CH.sub.2 NO.sub.2 or CH.sub.2 NH.sub.2 ; and R.sup.2 is NHCH.sub.2 CH.sub.2 Cl or N(CH.sub.2 Ch.sub.2 Cl).sub.2.

Abstract: Protective groups are provided which are suitable for masking phosphates and phosphonates. The protected compositions can be introduced in a biological system and then demasked under certain biological conditions. This method permits phosphates and phosphonates which would themselves degrade in the biological system and therefore be ineffective to be introduced in a protected form and late released under the proper conditions.

Abstract: A compound having the structure ##STR1## wherein R is CH.sub.3 or C.sub.2 H.sub.5 1; R.sup.1 is NH.sub.2, NHCH.sub.3, NHC.sub.2 H.sub.5, NHC.sub.2 H.sub.4 Cl, N(CH.sub.3).sub.2, N(C.sub.2 H.sub.5).sub.2, N(C.sub.2 H.sub.4 Cl).sub.2, OCH.sub.3, C.sub.2 H.sub.5, CH.sub.3, or C.sub.2 H.sub.5, and R.sup.2 is N(C.sub.2 H.sub.4 Cl).sub.2 or NH C.sub.2 H.sub.4 Cl.These compounds may be used to eliminate occult leukemic clonogenic cells from bone marrow by contacting the bone marrow with a solution comprising levels of said compound sufficient to eliminate occult leukemic clonogenic cells. Analogously tumor cells in a host or organ of a host may be eliminated by treatment of the host or host's organ with a compound of this description.Compounds of this description are stable aldophosphamide analogs activatable by the action of an esterase and a subsequent E-2 elimination reaction to form acrolein and a phosphoramidic mustard of the formula: ##STR2## wherein R is NH.sub.2, NHCH.sub.3, NHC.sub.2 H.sub.5, NHC.sub.2 H.

Abstract: Protective groups are provided which are suitable for masking phosphates and phosphonates. The protected compositions can be introduced in a biological system and then demasked under certain biological conditions. This method permits phosphates and phosphonates which would themselves degrade in the biological system and therefore be ineffective to be introduced in a protected form and late released under the proper conditions.